Product Information

SIMVASTATIN 40 MG TABLET is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.0516 per EA under NDC 69367037609. Its NADAC has been published 73 times since Jul 2, 2025.

FDA first approved this application on Nov 27, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SIMVASTATIN 40 MG TABLET

Simvastatin
$0.0516per EA

Strength

40 mg/1

NDC

69367037609

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

SIMVASTATIN

Approval Type

Generic (ANDA)

FDA Application

ANDA211394

FDA Approved

11/27/2024

TE Code

AB

On Market Since

4/14/2025

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for SIMVASTATIN 40 MG TABLET has been published 73 times since Jul 2, 2025, and over the history we have for it it has declined 4.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0516 per EA
All-time high$0.0547 (Apr 15, 2026)
All-time low$0.0516 (Nov 18, 2026)
52-week high$0.0547
52-week low$0.0516
Median price$0.0538
Average price$0.0537
Largest weekly change-2.8% (Oct 21, 2026)
Weeks tracked73
Tracking sinceJul 2, 2025

Price History

1W

-1.3%

1M

-4.1%

3M

-5.0%

6M

-4.3%

1Y

-2.5%

3Y

N/A

5Y

N/A

All

-4.7%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SIMVASTATIN 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SIMVASTATIN 40 MG TABLET, manufactured by Westminster Pharmaceuticals LLC, is $0.0516 per EA (NDC 69367037609), effective Nov 18, 2026.

How has the price of SIMVASTATIN 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for SIMVASTATIN 40 MG TABLET has declined 4.7%. It has been tracked across 73 weekly CMS publications since Jul 2, 2025.

What are the highest and lowest recorded NADAC prices for SIMVASTATIN 40 MG TABLET?

Since Jul 2, 2025, the NADAC for SIMVASTATIN 40 MG TABLET has ranged from a low of $0.0516 (Nov 18, 2026) to a high of $0.0547 (Apr 15, 2026), with a median of $0.0538 per EA.

Are there cheaper alternatives to SIMVASTATIN 40 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SIMVASTATIN 40 MG TABLET, is $0.0410 per EA — about 21% below SIMVASTATIN 40 MG TABLET.

Who manufactures SIMVASTATIN 40 MG TABLET?

SIMVASTATIN 40 MG TABLET (NDC 69367037609) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.